Faisal M. Sanai

6.3k total citations
108 papers, 1.7k citations indexed

About

Faisal M. Sanai is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Faisal M. Sanai has authored 108 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Epidemiology, 84 papers in Hepatology and 16 papers in Surgery. Recurrent topics in Faisal M. Sanai's work include Liver Disease Diagnosis and Treatment (73 papers), Hepatitis C virus research (61 papers) and Hepatitis B Virus Studies (53 papers). Faisal M. Sanai is often cited by papers focused on Liver Disease Diagnosis and Treatment (73 papers), Hepatitis C virus research (61 papers) and Hepatitis B Virus Studies (53 papers). Faisal M. Sanai collaborates with scholars based in Saudi Arabia, United States and Egypt. Faisal M. Sanai's co-authors include Khalid Bzeizi, Ayman A. Abdo, Khalid Alswat, Ahmed A. Al‐Qahtani, Mohammed N. Al‐Ahdal, Hamad I. Al‐Ashgar, Mashael R. Al‐Anazi, Ali Albenmousa, Waleed Al–Hamoudi and Abdulrahman Aljumah and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Faisal M. Sanai

103 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faisal M. Sanai Saudi Arabia 22 1.0k 892 418 204 135 108 1.7k
Sabahattin Kaymakoğlu Türkiye 23 1.1k 1.0× 1.0k 1.2× 525 1.3× 250 1.2× 63 0.5× 147 1.9k
Sheng‐Nan Lu Taiwan 28 1.6k 1.6× 1.7k 1.9× 364 0.9× 173 0.8× 87 0.6× 72 2.3k
Kuo‐Chin Chang Taiwan 24 947 0.9× 877 1.0× 328 0.8× 200 1.0× 100 0.7× 82 1.4k
John Boitnott United States 15 1.1k 1.0× 1.2k 1.3× 357 0.9× 173 0.8× 44 0.3× 20 1.7k
Mauricio Lisker‐Melman United States 23 2.0k 1.9× 2.3k 2.6× 278 0.7× 248 1.2× 44 0.3× 79 2.8k
Evangelos Akriviadis Greece 28 1.9k 1.8× 2.0k 2.3× 894 2.1× 261 1.3× 123 0.9× 80 2.8k
Guillaume Pénaranda France 28 1.5k 1.5× 1.6k 1.7× 525 1.3× 298 1.5× 31 0.2× 120 2.7k
Carolynne Schwarze‐Zander Germany 20 570 0.6× 463 0.5× 131 0.3× 252 1.2× 195 1.4× 57 1.1k
Liang‐Yen Wang Taiwan 30 2.3k 2.2× 2.4k 2.7× 244 0.6× 196 1.0× 42 0.3× 101 3.0k
Gabriella Verucchi Italy 21 1.5k 1.4× 1.5k 1.7× 133 0.3× 286 1.4× 152 1.1× 86 2.0k

Countries citing papers authored by Faisal M. Sanai

Since Specialization
Citations

This map shows the geographic impact of Faisal M. Sanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faisal M. Sanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faisal M. Sanai more than expected).

Fields of papers citing papers by Faisal M. Sanai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faisal M. Sanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faisal M. Sanai. The network helps show where Faisal M. Sanai may publish in the future.

Co-authorship network of co-authors of Faisal M. Sanai

This figure shows the co-authorship network connecting the top 25 collaborators of Faisal M. Sanai. A scholar is included among the top collaborators of Faisal M. Sanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faisal M. Sanai. Faisal M. Sanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abaalkhail, Faisal, Faisal M. Sanai, Khalid Alswat, et al.. (2025). Metabolic dysfunction-associated steatotic liver disease management in Saudi Arabia: A modified Delphi-based adaptation of international standards. Saudi Journal of Gastroenterology. 32(2). 104–120. 1 indexed citations
2.
Alhazzani, Waleed, et al.. (2025). A bibliometric analysis of a decade’s research on metabolic dysfunction-associated steatotic liver disease in the Arab world. Saudi Journal of Gastroenterology. 31(3). 157–167. 2 indexed citations
3.
Alalwan, Abduljaleel, et al.. (2025). Large duct primary sclerosing cholangitis with or without inflammatory bowel disease in Saudi patients. Saudi Journal of Gastroenterology. 31(6). 356–366.
4.
El‐Kassas, Mohamed, Marcela Villota‐Rivas, Khalid Alswat, et al.. (2025). Metabolic Dysfunction‐Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda. Liver International. 45(6). e70108–e70108. 2 indexed citations
5.
6.
Alqahtani, Saleh A., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2024). Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt. Journal of Viral Hepatitis. 31(6). 300–308. 4 indexed citations
7.
Alqahtani, Saleh A., Yusuf Yılmaz, Mohamed El‐Kassas, et al.. (2024). Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region. Annals of Hepatology. 30(1). 101569–101569. 6 indexed citations
8.
9.
Sanai, Faisal M., et al.. (2022). Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels. Saudi Journal of Gastroenterology. 28(5). 341–347. 2 indexed citations
10.
Abaalkhail, Faisal, Waleed K. Al‐Hamoudi, Saad Alghamdi, et al.. (2021). SASLT practice guidelines for the management of Hepatitis B virus – An update. Saudi Journal of Gastroenterology. 27(3). 115–126. 11 indexed citations
11.
Alswat, Khalid, Abdulrahman Aljumah, Faisal M. Sanai, et al.. (2018). Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030. Saudi Journal of Gastroenterology. 24(4). 211–219. 98 indexed citations
12.
Babatin, Mohammed A., et al.. (2018). Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients. Saudi Journal of Gastroenterology. 25(1). 55–55. 3 indexed citations
13.
Sanai, Faisal M., Mohammed A. Babatin, Khalid Alswat, et al.. (2017). Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B. BMC Gastroenterology. 17(1). 101–101. 9 indexed citations
14.
Al‐Qahtani, Ahmed A., Mashael R. Al‐Anazi, Ayman A. Abdo, et al.. (2015). Correlation between Genetic Variations and Serum Level of Interleukin 28B with Virus Genotypes and Disease Progression in Chronic Hepatitis C Virus Infection. Journal of Immunology Research. 2015. 1–10. 23 indexed citations
15.
Al‐Hamoudi, Waleed K., Ahmed Helmy, Nehal Khamis, et al.. (2015). The role of Fibroscan in predicting the presence of varices in patients with cirrhosis. European Journal of Gastroenterology & Hepatology. 27(11). 1307–1312. 7 indexed citations
16.
Al‐Qahtani, Ahmed A., Mashael R. Al‐Anazi, Fahad Al-Zoghaibi, et al.. (2014). The Association of Toll-Like Receptor 4 Polymorphism with Hepatitis C Virus Infection in Saudi Arabian Patients. BioMed Research International. 2014. 1–9. 21 indexed citations
17.
Almadi, Majid A., et al.. (2011). New insights into gastrointestinal and hepatic granulomatous disorders. Nature Reviews Gastroenterology & Hepatology. 8(8). 455–466. 26 indexed citations
18.
Sanai, Faisal M., Ahmed Helmy, Cheryl Dale, et al.. (2011). Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C. Liver International. 31(7). 1039–1046. 8 indexed citations
19.
Binamer, Yousef, et al.. (2010). Interferon‐induced vitiligo in hepatitis C patients: a case series. International Journal of Dermatology. 49(7). 829–833. 16 indexed citations
20.
Saleemi, Sarfraz, et al.. (2008). Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension. SHILAP Revista de lepidopterología. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabahattin Kaymakoğlu Breakdown of academic impact, for papers by Sheng‐Nan Lu Breakdown of academic impact, for papers by Kuo‐Chin Chang Breakdown of academic impact, for papers by John Boitnott Breakdown of academic impact, for papers by Mauricio Lisker‐Melman Breakdown of academic impact, for papers by Evangelos Akriviadis Breakdown of academic impact, for papers by Guillaume Pénaranda Breakdown of academic impact, for papers by Carolynne Schwarze‐Zander Breakdown of academic impact, for papers by Liang‐Yen Wang Breakdown of academic impact, for papers by Gabriella Verucchi
Rankless by CCL
2026